non-beta-lactam PBP inhibitors (Entasis Therapeutics)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namenon-beta-lactam PBP inhibitors (Entasis Therapeutics)
Drug Alias NameETX-054
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCarbapenem-Resistant InfectionMultidrug-Resistant InfectionBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEntasis Therapeutics Holdings Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEntasis Therapeutics Holdings Inc
Active IndicationsN/A
Inactive IndicationsCarbapenem-Resistant InfectionMultidrug-Resistant InfectionBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A